acetone has been researched along with Cardiac Failure in 16 studies
methyl ketone : A ketone of formula RC(=O)CH3 (R =/= H).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Exhaled breath acetone (EBA) has been described as a new biomarker of heart failure (HF) diagnosis." | 7.96 | Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients. ( Ayub-Ferreira, SM; Bacal, F; Batista, GL; Bernardez-Pereira, S; Bocchi, EA; Fernandes, F; Gioli-Pereira, L; Gutz, IGR; Issa, VS; Krieger, JE; Mangini, S; Mansur, AJ; Marcondes-Braga, FG; Pereira, AC, 2020) |
| "Exhaled acetone concentration is one of the expected compounds to be a breath biomarker in heart failure." | 7.88 | Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure. ( Ishida, T; Kobayashi, A; Kunii, H; Nakazato, K; Oikawa, M; Saitoh, SI; Sato, T; Shimouchi, A; Suzuki, H; Suzuki, S; Takeishi, Y; Yamaki, T; Yokokawa, T; Yoshihisa, A, 2018) |
| "In heart failure patients, exhaled acetone concentration, a noninvasive biomarker, is increased according to heart failure severity." | 7.85 | Change of Exhaled Acetone Concentration in a Diabetic Patient with Acute Decompensated Heart Failure. ( Houtsuki, Y; Ichijo, Y; Matsumoto, Y; Nakazato, K; Oikawa, M; Saitoh, SI; Shimouchi, A; Sugimoto, K; Suzuki, H; Takeishi, Y; Yokokawa, T; Yoshihisa, A, 2017) |
| "Breath acetone is a noninvasive biomarker of heart failure; however, its significance in heart failure patients with diabetes mellitus has yet to be clarified." | 7.85 | Elevated exhaled acetone concentration in stage C heart failure patients with diabetes mellitus. ( Ishida, T; Kobayashi, A; Kunii, H; Nakazato, K; Oikawa, M; Saitoh, SI; Sato, T; Shimouchi, A; Suzuki, H; Suzuki, S; Takeishi, Y; Yamaki, T; Yokokawa, T; Yoshihisa, A, 2017) |
| "We hypothesized that exhaled acetone concentration (EAC), reflecting altered blood ketone body metabolism and increased acetone exhaust because of pulmonary congestion in heart failure (HF), would correlate with hemodynamic parameters in patients with non-ischemic chronic HF." | 7.83 | Exhaled Acetone Concentration Is Related to Hemodynamic Severity in Patients With Non-Ischemic Chronic Heart Failure. ( Aiba, T; Anzai, T; Jinno, N; Kanzaki, H; Kusano, K; Nagai, T; Ogawa, H; Shibata, A; Shimouchi, A; Shirai, M; Sugano, Y; Takeishi, Y; Yasuda, S; Yokokawa, T, 2016) |
| "Exhaled breath acetone (EBA) has been described as a new biomarker of heart failure (HF) diagnosis." | 3.96 | Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients. ( Ayub-Ferreira, SM; Bacal, F; Batista, GL; Bernardez-Pereira, S; Bocchi, EA; Fernandes, F; Gioli-Pereira, L; Gutz, IGR; Issa, VS; Krieger, JE; Mangini, S; Mansur, AJ; Marcondes-Braga, FG; Pereira, AC, 2020) |
| "Exhaled acetone concentration is one of the expected compounds to be a breath biomarker in heart failure." | 3.88 | Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure. ( Ishida, T; Kobayashi, A; Kunii, H; Nakazato, K; Oikawa, M; Saitoh, SI; Sato, T; Shimouchi, A; Suzuki, H; Suzuki, S; Takeishi, Y; Yamaki, T; Yokokawa, T; Yoshihisa, A, 2018) |
| "In heart failure patients, exhaled acetone concentration, a noninvasive biomarker, is increased according to heart failure severity." | 3.85 | Change of Exhaled Acetone Concentration in a Diabetic Patient with Acute Decompensated Heart Failure. ( Houtsuki, Y; Ichijo, Y; Matsumoto, Y; Nakazato, K; Oikawa, M; Saitoh, SI; Shimouchi, A; Sugimoto, K; Suzuki, H; Takeishi, Y; Yokokawa, T; Yoshihisa, A, 2017) |
| "Breath acetone is a noninvasive biomarker of heart failure; however, its significance in heart failure patients with diabetes mellitus has yet to be clarified." | 3.85 | Elevated exhaled acetone concentration in stage C heart failure patients with diabetes mellitus. ( Ishida, T; Kobayashi, A; Kunii, H; Nakazato, K; Oikawa, M; Saitoh, SI; Sato, T; Shimouchi, A; Suzuki, H; Suzuki, S; Takeishi, Y; Yamaki, T; Yokokawa, T; Yoshihisa, A, 2017) |
| "We hypothesized that exhaled acetone concentration (EAC), reflecting altered blood ketone body metabolism and increased acetone exhaust because of pulmonary congestion in heart failure (HF), would correlate with hemodynamic parameters in patients with non-ischemic chronic HF." | 3.83 | Exhaled Acetone Concentration Is Related to Hemodynamic Severity in Patients With Non-Ischemic Chronic Heart Failure. ( Aiba, T; Anzai, T; Jinno, N; Kanzaki, H; Kusano, K; Nagai, T; Ogawa, H; Shibata, A; Shimouchi, A; Shirai, M; Sugano, Y; Takeishi, Y; Yasuda, S; Yokokawa, T, 2016) |
| "These results suggested that in patients with heart failure, MEE elevation was associated with significant changes in serum metabolomics profiles, especially the concentration of 3-hydroxybutyrate, acetone and succinate." | 3.80 | 1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients. ( Du, Z; Huang, Y; Lai, W; Ren, H; Shen, A; Su, L; Wang, P; Xie, Z; Xu, D; Zeng, Q, 2014) |
| "Treatment with empagliflozin did not affect ketone body concentrations in patients with acute HF." | 3.30 | Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial. ( Beusekamp, JC; Boorsma, EM; Connelly, MA; Damman, K; DE-Boer, RA; Dullaart, RPF; VAN-DER-Meer, P; VAN-Veldhuisen, DJ; Voorrips, SN; Voors, AA; Westenbrink, BD, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 5 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Gouzi, F | 1 |
| Ayache, D | 1 |
| Hédon, C | 1 |
| Molinari, N | 1 |
| Vicet, A | 1 |
| Voorrips, SN | 1 |
| Boorsma, EM | 1 |
| Beusekamp, JC | 1 |
| DE-Boer, RA | 1 |
| Connelly, MA | 1 |
| Dullaart, RPF | 1 |
| VAN-DER-Meer, P | 1 |
| VAN-Veldhuisen, DJ | 1 |
| Voors, AA | 1 |
| Damman, K | 1 |
| Westenbrink, BD | 1 |
| Gladding, PA | 1 |
| Cooper, M | 1 |
| Young, R | 1 |
| Loader, S | 1 |
| Smith, K | 1 |
| Zarate, E | 1 |
| Green, S | 1 |
| Villas Boas, SG | 1 |
| Shepherd, P | 1 |
| Kakadiya, P | 1 |
| Thorstensen, E | 1 |
| Keven, C | 1 |
| Coe, M | 1 |
| Jüllig, M | 1 |
| Zhang, E | 1 |
| Schlegel, TT | 1 |
| Biagini, D | 1 |
| Pugliese, NR | 1 |
| Vivaldi, FM | 1 |
| Ghimenti, S | 1 |
| Lenzi, A | 1 |
| De Angelis, F | 1 |
| Ripszam, M | 1 |
| Bruderer, T | 1 |
| Armenia, S | 1 |
| Cappeli, F | 1 |
| Taddei, S | 1 |
| Masi, S | 1 |
| Francesco, FD | 1 |
| Lomonaco, T | 1 |
| Marcondes-Braga, FG | 3 |
| Gioli-Pereira, L | 1 |
| Bernardez-Pereira, S | 1 |
| Batista, GL | 3 |
| Mangini, S | 3 |
| Issa, VS | 3 |
| Fernandes, F | 1 |
| Bocchi, EA | 3 |
| Ayub-Ferreira, SM | 3 |
| Mansur, AJ | 1 |
| Gutz, IGR | 2 |
| Krieger, JE | 1 |
| Pereira, AC | 2 |
| Bacal, F | 3 |
| Yokokawa, T | 5 |
| Ichijo, Y | 1 |
| Houtsuki, Y | 1 |
| Matsumoto, Y | 1 |
| Oikawa, M | 3 |
| Yoshihisa, A | 3 |
| Sugimoto, K | 1 |
| Nakazato, K | 3 |
| Suzuki, H | 3 |
| Saitoh, SI | 3 |
| Shimouchi, A | 5 |
| Takeishi, Y | 4 |
| Sato, T | 2 |
| Suzuki, S | 2 |
| Kobayashi, A | 2 |
| Yamaki, T | 2 |
| Kunii, H | 2 |
| Ishida, T | 2 |
| Samara, MA | 1 |
| Tang, WH | 1 |
| Cikach, F | 1 |
| Gul, Z | 1 |
| Tranchito, L | 1 |
| Paschke, KM | 1 |
| Viterna, J | 1 |
| Wu, Y | 1 |
| Laskowski, D | 1 |
| Dweik, RA | 1 |
| Du, Z | 1 |
| Shen, A | 1 |
| Huang, Y | 1 |
| Su, L | 1 |
| Lai, W | 1 |
| Wang, P | 1 |
| Xie, Z | 2 |
| Zeng, Q | 1 |
| Ren, H | 1 |
| Xu, D | 1 |
| Sugano, Y | 2 |
| Shibata, A | 2 |
| Nakayama, T | 1 |
| Ohara, T | 1 |
| Jinno, N | 2 |
| Kanzaki, H | 2 |
| Anzai, T | 2 |
| Nagai, T | 1 |
| Aiba, T | 1 |
| Kusano, K | 1 |
| Shirai, M | 1 |
| Yasuda, S | 1 |
| Ogawa, H | 1 |
| Gutz, IG | 1 |
| Saldiva, PH | 1 |
| Saldiva, PHN | 1 |
| Kupari, M | 1 |
| Lommi, J | 1 |
| Ventilä, M | 1 |
| Karjalainen, U | 1 |
| Lohmann, DP | 1 |
| Pennington, DG | 1 |
| McBride, LR | 1 |
1 review available for acetone and Cardiac Failure
| Article | Year |
|---|---|
Breath acetone concentration: too heterogeneous to constitute a diagnosis or prognosis biomarker in heart failure? A systematic review and meta-analysis.
Topics: Acetone; Biomarkers; Breath Tests; Heart Failure; Humans; Prognosis | 2021 |
1 trial available for acetone and Cardiac Failure
| Article | Year |
|---|---|
Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Acetone; Heart Failure; Humans; Ketone Bodies | 2023 |
14 other studies available for acetone and Cardiac Failure
| Article | Year |
|---|---|
Metabolomics and a Breath Sensor Identify Acetone as a Biomarker for Heart Failure.
Topics: Acetone; Biomarkers; Heart Failure; Humans; Metabolomics; Stroke Volume | 2022 |
Breath analysis combined with cardiopulmonary exercise testing and echocardiography for monitoring heart failure patients: the AEOLUS protocol.
Topics: Acetone; Breath Tests; Diabetes Mellitus, Type 2; Echocardiography; Exercise Test; Heart Failure; Hu | 2023 |
Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients.
Topics: Acetone; Adult; Aged; Exhalation; Female; Heart Failure; Humans; Male; Middle Aged; Stroke Volume; V | 2020 |
Change of Exhaled Acetone Concentration in a Diabetic Patient with Acute Decompensated Heart Failure.
Topics: Acetone; Acute Disease; Aged; Biomarkers; Breath Tests; Diabetes Mellitus, Type 2; Disease Progressi | 2017 |
Elevated exhaled acetone concentration in stage C heart failure patients with diabetes mellitus.
Topics: Acetone; Aged; Biomarkers; Breath Tests; Cross-Sectional Studies; Diabetes Complications; Echocardio | 2017 |
Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure.
Topics: Acetone; Aged; Biomarkers; Breath Tests; Chromatography, Gas; Echocardiography; Exhalation; Female; | 2018 |
Single exhaled breath metabolomic analysis identifies unique breathprint in patients with acute decompensated heart failure.
Topics: Acetone; Breath Tests; Exhalation; Feasibility Studies; Heart Failure; Humans; Metabolomics; Natriur | 2013 |
1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients.
Topics: 3-Hydroxybutyric Acid; Acetone; Adult; Aged; Aged, 80 and over; Energy Metabolism; Female; Heart Fai | 2014 |
A case of acute decompensated heart failure evaluated by series of exhaled acetone concentrations as noninvasive biomarker of heart failure severity.
Topics: Acetone; Acute Disease; Aged, 80 and over; Biomarkers; Breath Tests; Exhalation; Female; Heart Failu | 2016 |
Exhaled Acetone Concentration Is Related to Hemodynamic Severity in Patients With Non-Ischemic Chronic Heart Failure.
Topics: Acetone; Biomarkers; Breath Tests; Case-Control Studies; Chronic Disease; Exhalation; Heart Failure; | 2016 |
Impact of Exhaled Breath Acetone in the Prognosis of Patients with Heart Failure with Reduced Ejection Fraction (HFrEF). One Year of Clinical Follow-up.
Topics: Acetone; Adult; Breath Tests; Exhalation; Female; Follow-Up Studies; Heart Failure; Heart Transplant | 2016 |
Exhaled acetone as a new biomaker of heart failure severity.
Topics: Acetone; Adult; Biomarkers; Breath Tests; Case-Control Studies; Exhalation; Female; Heart Failure; H | 2012 |
Breath acetone in congestive heart failure.
Topics: Acetone; Adult; Aged; Breath Tests; Chromatography, Gas; Female; Heart Failure; Humans; Ketosis; Lin | 1995 |
Acetone: a hazard to plastic medical products--a case report.
Topics: Acetone; Equipment Failure; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged | 1991 |